Toggle light / dark theme

Blood protein clocks flag higher risks of death and chronic disease

Organ-specific age gaps showed strong associations with cancers affecting the corresponding organ. The strongest association was observed between kidney biological age and renal cancer (HR, 1.6). Organ-specific aging in lungs and intestines also increased the risk of lung cancer and stomach cancer, respectively (HR, 1.4 for both). The sensitivity analysis yielded largely similar results, except for attenuations in kidney and lung cancer, indicating the robustness of the primary findings.

The Global Proteomic Aging Clock predicted mortality from any cause as accurately as conventional risk factors. Combining the findings with established risk factors further improved mortality prediction compared with using risk factors alone.

One injection reversed osteoarthritis in weeks

Researchers from the University of Colorado Boulder, CU Anschutz, and Colorado State University have developed a set of experimental treatments that may help aging and damaged joints repair themselves in a matter of weeks. The therapies have shown promising results in animal studies, where they reversed signs of osteoarthritis and restored joint health.

The new approaches include a regenerative injection designed to be administered directly into a joint, as well as a biomaterial-based repair system that encourages the body’s own cells to rebuild damaged cartilage.

The work recently received a major boost from the federal Advanced Research Projects Agency for Health (ARPA-H), which announced that the team will move forward to the next stage of a project worth up to $33.5 million. The research is part of the ARPA-H Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, led by ARPA-H Program Manager Dr. Ross Uhrich.

Therapeutic inhibition of telomeric DNA damage response rescues hematopoietic dysfunction driven by telomere shortening and aging

Oppezzo and colleagues report that therapeutically blocking telomeric DNA damage signaling reduces senescence and inflammation and restores hematopoietic function in telomerase-deficient and physiologically aged mice.

Rare aging disorder links ‘biological clock’ to disease

Scientists have discovered a rare genetic condition that causes people to age at a much faster rate, offering fresh insights into the aging process. The study shows for the first time how a “biological clock” present in every cell of the body could contribute to age-related diseases.

Experts say the findings could support the design of future medicines to counter diseases linked to older age, as life expectancies continue to rise across the globe.

The study is published in the journal Nature Genetics.

Transhumanism 101 with Natasha Vita-More

In 2012, transhumanism was still being called “the most dangerous idea in the world.”

Fourteen years later, we’re casually debating brain-computer interfaces, radical life extension, and what it even means to stay “human” in an age of AI. The fringe became the headline.

So I went back into the Singularity. FM archive and pulled my conversation with Dr. Natasha Vita-More, often called the first female philosopher of transhumanism. We recorded “Transhumanism 101” to cut through the fear and the ideology and get to the actual ideas.

We covered a lot:

Why Mary Shelley’s Frankenstein still shapes how we react to enhancement technology, two centuries later. Where the panic comes from (Bill Joy, Fukuyama) and why most of it misses the point. The real differences between transhuman, posthuman, and cyborg. And critical thinking as a core tenet, not a footnote, of the whole project.

The line that stuck with me, and that lands even harder today: “Get creative about the future.”

3 Age-Reversal Therapies Being Tested Right Now

Most people still think Longevity Escape Velocity is a distant future. But what if some of the technologies that could make it possible are already being tested right now?

In this video, we look at three emerging longevity therapies: partial epigenetic reprogramming, senescent-cell removal, and stem-cell based repair. Some are already in human trials, while others are still early and experimental, but together they show how medicine may begin shifting from treating age-related disease to repairing parts of aging itself.

1:16 — THERAPY #1 — Partial epigenetic reprogramming.
3:34 — THERAPY #2 — SenoVax immune cleanup.
5:24 — THERAPY #3 — Lomecel — B — stem-cell therapy.
7:07 — CONCLUSION — From theory to repair.

📚 SOURCES AND STUDIES MENTIONED

ER-100 / partial epigenetic reprogramming:

/* */